Literature DB >> 20634582

Frontotemporal dementia phenotype associated with MAPT gene duplication.

Anne Rovelet-Lecrux1, Didier Hannequin, Olivier Guillin, Solenn Legallic, Snejana Jurici, David Wallon, Thierry Frebourg, Dominique Campion.   

Abstract

Microduplications at 17q21.31 have recently been reported in children with mental retardation, autism spectrum disorders and/or dysmorphic features, as well as in a single schizophrenic patient. This rearrangement encompasses the microtubule associated protein tau (MAPT) gene, mutations of which are a major cause of frontotemporal lobar degeneration (FTLD). However, no 17q21.31 microduplication has been so far identified in this condition. We screened chromosomal rearrangements in FTLD patients using quantitative multiplex PCR of short fluorescent fragments and high resolution array CGH. We found a 439-kb microduplication at the 17q21.31 locus encompassing the MAPT, IMP5, CRHR1, and STH genes in the index case of a family in which three patients have developed a FTLD phenotype associated with marked memory impairment. None of these patients had mental retardation or dysmorphic features. Since no pathological examination was available, we are not certain that this case corresponds to a FTLD with neuronal and glial tau inclusions (FTLD-tau), and we cannot exclude that any other gene included in the rearrangement might be responsible for the neurodegenerative process. However, the clinical phenotype of the three patients is functionally consistent with the regional pattern of lesions previously reported in mice overexpressing human tau.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20634582     DOI: 10.3233/JAD-2010-100441

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  19 in total

Review 1.  Synapse assembly and neurodevelopmental disorders.

Authors:  Philip Washbourne
Journal:  Neuropsychopharmacology       Date:  2014-07-03       Impact factor: 7.853

2.  The future of genetic research on neurodegeneration.

Authors:  Christine Van Broeckhoven
Journal:  Nat Med       Date:  2010-09-21       Impact factor: 53.440

3.  Mendelian and Sporadic FTD: Disease Risk and Avenues from Genetics to Disease Pathways Through In Silico Modelling.

Authors:  Claudia Manzoni; Raffaele Ferrari
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Frontotemporal dementia: from Mendelian genetics towards genome wide association studies.

Authors:  Raffaele Ferrari; John Hardy; Parastoo Momeni
Journal:  J Mol Neurosci       Date:  2011-09-06       Impact factor: 3.444

5.  miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo.

Authors:  Pascal Y Smith; Julia Hernandez-Rapp; Francis Jolivette; Cynthia Lecours; Kanchan Bisht; Claudia Goupil; Veronique Dorval; Sepideh Parsi; Françoise Morin; Emmanuel Planel; David A Bennett; Francisco-Jose Fernandez-Gomez; Nicolas Sergeant; Luc Buée; Marie-Ève Tremblay; Frédéric Calon; Sébastien S Hébert
Journal:  Hum Mol Genet       Date:  2015-09-11       Impact factor: 6.150

6.  Rare autosomal copy number variations in early-onset familial Alzheimer's disease.

Authors:  B V Hooli; Z M Kovacs-Vajna; K Mullin; M A Blumenthal; M Mattheisen; C Zhang; C Lange; G Mohapatra; L Bertram; R E Tanzi
Journal:  Mol Psychiatry       Date:  2013-06-11       Impact factor: 15.992

7.  17q21.31 duplication causes prominent tau-related dementia with increased MAPT expression.

Authors:  K Le Guennec; O Quenez; G Nicolas; D Wallon; S Rousseau; A-C Richard; J Alexander; P Paschou; C Charbonnier; C Bellenguez; B Grenier-Boley; D Lechner; M-T Bihoreau; R Olaso; A Boland; V Meyer; J-F Deleuze; P Amouyel; H M Munter; G Bourque; M Lathrop; T Frebourg; R Redon; L Letenneur; J-F Dartigues; O Martinaud; O Kalev; S Mehrabian; L Traykov; T Ströbel; I Le Ber; P Caroppo; S Epelbaum; T Jonveaux; F Pasquier; A Rollin-Sillaire; E Génin; L Guyant-Maréchal; G G Kovacs; J-C Lambert; D Hannequin; D Campion; A Rovelet-Lecrux
Journal:  Mol Psychiatry       Date:  2016-12-13       Impact factor: 15.992

Review 8.  Frontotemporal dementia: latest evidence and clinical implications.

Authors:  Juan Joseph Young; Mallika Lavakumar; Deena Tampi; Silpa Balachandran; Rajesh R Tampi
Journal:  Ther Adv Psychopharmacol       Date:  2017-11-10

9.  A comprehensive screening of copy number variability in dementia with Lewy bodies.

Authors:  Celia Kun-Rodrigues; Tatiana Orme; Susana Carmona; Dena G Hernandez; Owen A Ross; John D Eicher; Claire Shepherd; Laura Parkkinen; Lee Darwent; Michael G Heckman; Sonja W Scholz; Juan C Troncoso; Olga Pletnikova; Ted Dawson; Liana Rosenthal; Olaf Ansorge; Jordi Clarimon; Alberto Lleo; Estrella Morenas-Rodriguez; Lorraine Clark; Lawrence S Honig; Karen Marder; Afina Lemstra; Ekaterina Rogaeva; Peter St George-Hyslop; Elisabet Londos; Henrik Zetterberg; Imelda Barber; Anne Braae; Kristelle Brown; Kevin Morgan; Claire Troakes; Safa Al-Sarraj; Tammaryn Lashley; Janice Holton; Yaroslau Compta; Vivianna Van Deerlin; Geidy E Serrano; Thomas G Beach; Suzanne Lesage; Douglas Galasko; Eliezer Masliah; Isabel Santana; Pau Pastor; Monica Diez-Fairen; Miquel Aguilar; Pentti J Tienari; Liisa Myllykangas; Minna Oinas; Tamas Revesz; Andrew Lees; Brad F Boeve; Ronald C Petersen; Tanis J Ferman; Valentina Escott-Price; Neill Graff-Radford; Nigel J Cairns; John C Morris; Stuart Pickering-Brown; David Mann; Glenda M Halliday; John Hardy; John Q Trojanowski; Dennis W Dickson; Andrew Singleton; David J Stone; Rita Guerreiro; Jose Bras
Journal:  Neurobiol Aging       Date:  2018-10-24       Impact factor: 4.673

Review 10.  Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia.

Authors:  Alberto Benussi; Alessandro Padovani; Barbara Borroni
Journal:  Front Aging Neurosci       Date:  2015-09-01       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.